GlaxoSmithKline PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.

Japan approves first RSV vaccine for adults 50-59 

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

GlaxoSmithKline PLC (GSK LN)

Japan approves first RSV vaccine for adults 50-59

Director/PDMR Shareholding

GLISTEN Trial of Linerixibat Meets Endpoint

GSK announces overall survival results for Blenrep

Director/PDMR Shareholding

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)